Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 3 | $460,539 |
Sells | 14 | $5,598,609 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
14 Feb 2024 20:35 | IRWD | IRONWOOD PHARMACEUTICALS INC | MCCOURT THOMAS A | Chief Executive Officer | 12 Feb 2024 | Sale | 177,164 | 15.24 | 2,699,979 | D |
14 Feb 2024 21:01 | IRWD | IRONWOOD PHARMACEUTICALS INC | JOHN MINARDO | Chief Legal Officer | 12 Feb 2024 | Sale | 47,380 | 15.24 | 722,071 | D |
14 Feb 2024 20:53 | IRWD | IRONWOOD PHARMACEUTICALS INC | SHETZLINE MICHAEL | CMO,SVP,Head-Res&Drug | 12 Feb 2024 | Sale | 38,618 | 15.24 | 588,538 | D |
22 May 2024 16:05 | IRWD | IRONWOOD PHARMACEUTICALS INC | MCCOURT THOMAS A | Chief Executive Officer | 20 May 2024 | Sale | 67,618 | 6.45 | 436,136 | D |
18 Sep 2023 17:07 | IRWD | IRONWOOD PHARMACEUTICALS INC | EMANY SRAVAN KUMAR | SVP, Chief Financial Officer | 15 Sep 2023 | Purchase | 36,072 | 8.32 | 300,119 | D |
01 Jun 2023 17:45 | IRWD | IRONWOOD PHARMACEUTICALS INC | MCCOURT THOMAS A | Chief Executive Officer | 30 May 2023 | Sale | 26,632 | 10.7 | 284,962 | D |
14 Feb 2024 20:42 | IRWD | IRONWOOD PHARMACEUTICALS INC | DAVIS ANDREW | SVP, Chief Business Officer | 12 Feb 2024 | Sale | 9,846 | 15.24 | 150,053 | D |
22 May 2024 16:05 | IRWD | IRONWOOD PHARMACEUTICALS INC | DAVIS ANDREW | SVP, Chief Business Officer | 20 May 2024 | Sale | 22,725 | 6.45 | 146,576 | D |
14 Feb 2024 20:50 | IRWD | IRONWOOD PHARMACEUTICALS INC | SILVER RONALD | Principal Accounting Officer | 12 Feb 2024 | Sale | 7,908 | 15.24 | 120,518 | D |
22 May 2024 16:05 | IRWD | IRONWOOD PHARMACEUTICALS INC | JOHN MINARDO | Chief Legal Officer | 20 May 2024 | Sale | 17,404 | 6.45 | 112,256 | D |
18 Dec 2023 16:09 | IRWD | IRONWOOD PHARMACEUTICALS INC | KESSLER MARLA L | Director | 14 Dec 2023 | Sale | 9,926 | 11.19 | 111,072 | D |
22 May 2024 16:05 | IRWD | IRONWOOD PHARMACEUTICALS INC | SHETZLINE MICHAEL | CMO,SVP,Head-Res&Drug | 20 May 2024 | Sale | 16,128 | 6.45 | 104,026 | D |
06 Mar 2024 16:05 | IRWD | IRONWOOD PHARMACEUTICALS INC | EMANY SRAVAN KUMAR | SVP, Chief Financial Officer | 04 Mar 2024 | Purchase | 10,684 | 9.38 | 100,216 | D |
16 Aug 2023 16:20 | IRWD | IRONWOOD PHARMACEUTICALS INC | JOHN MINARDO | Chief Legal Officer | 14 Aug 2023 | Sale | 7,045 | 10.04 | 70,732 | D |
08 Mar 2024 16:05 | IRWD | IRONWOOD PHARMACEUTICALS INC | DUANE JON R | Director | 06 Mar 2024 | Purchase | 6,920 | 8.7 | 60,204 | D |
22 Nov 2023 16:05 | IRWD | IRONWOOD PHARMACEUTICALS INC | DAVIS ANDREW | SVP, Chief Business Officer | 20 Nov 2023 | Sale | 3,287 | 9.69 | 31,851 | D |
16 Aug 2023 16:21 | IRWD | IRONWOOD PHARMACEUTICALS INC | SILVER RONALD | Principal Accounting Officer | 14 Aug 2023 | Sale | 1,976 | 10.04 | 19,839 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)